Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
iSONEP (sonepcizumab)
i
Other names:
LT1009, LT-1009, LT 1009
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Apollo Endosurgery, Pfizer
Drug class:
Angiogenesis inhibitor, S1P receptor modulator
Related drugs:
‹
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
TL-118 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
ABT-510 (0)
fingolimod (4)
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
TL-118 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
ABT-510 (0)
fingolimod (4)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login